sec filing
PP
NASDAQ · PPCB
Propanc Biopharma, Inc. Common Stock
Healthcare · Biotechnology
$1.08
Up+$0.04 (+3.70%)
Updated Aug 24, 2026, 4:23 PM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 9.77M
- P/E ratio
- -0.15
- Dividend yield
- 0.00%
- 52-week range
- $0.09 – $6.79
- Volume
- 25.22K
- Avg. volume
- 330.85K
Price performance
PPCB price history
1M range · 20 trading sessions · Daily adjusted prices
PPCB closed at $1.08 after 20 trading sessions, down 18.18% for the selected period.
- Last close
- $1.08
- Period change
- -18.18%
- Period low
- $0.99
- Period high
- $1.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $1.12 | $1.12 | $1.05 | $1.08 | 25.22K |
| Aug 20, 2026 | $1.13 | $1.18 | $1.10 | $1.10 | 20.83K |
| Aug 19, 2026 | $1.185 | $1.185 | $1.10 | $1.14 | 36.89K |
| Aug 18, 2026 | $1.12 | $1.1938 | $1.10 | $1.16 | 33.09K |
| Aug 17, 2026 | $1.25 | $1.27 | $1.15 | $1.15 | 46.6K |
| Aug 14, 2026 | $1.21 | $1.29 | $1.20 | $1.22 | 39.54K |
| Aug 13, 2026 | $1.24 | $1.26 | $1.20 | $1.22 | 34.46K |
| Aug 12, 2026 | $1.23 | $1.26 | $1.17 | $1.21 | 39.06K |
| Aug 11, 2026 | $1.18 | $1.24 | $1.16 | $1.17 | 44.17K |
| Aug 10, 2026 | $1.20 | $1.2378 | $1.065 | $1.15 | 83.63K |
| Aug 7, 2026 | $1.22 | $1.26 | $1.18 | $1.20 | 193.45K |
| Aug 6, 2026 | $1.25 | $1.60 | $1.10 | $1.36 | 1.23M |
| Aug 5, 2026 | $1.06 | $1.32 | $1.05 | $1.18 | 595K |
| Aug 4, 2026 | $1.10 | $1.10 | $0.9776 | $1.02 | 47.65K |
| Aug 3, 2026 | $1.02 | $1.07 | $1.00 | $1.05 | 75.6K |
| Jul 31, 2026 | $1.07 | $1.08 | $0.95 | $1.01 | 39.35K |
| Jul 30, 2026 | $1.00 | $1.0843 | $0.97 | $1.04 | 47.91K |
| Jul 29, 2026 | $1.19 | $1.24 | $0.95 | $0.99 | 187.71K |
| Jul 28, 2026 | $1.29 | $1.30 | $1.17 | $1.21 | 78.3K |
| Jul 27, 2026 | $1.33 | $1.3599 | $1.20 | $1.32 | 50.35K |
Latest PPCB news
The latest Smart Investors Daily articles mentioning PPCB.
Stock researchCompany · Financials
Loading stock research…

